ArticleScientific reports2017

Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab.

Giorgia Marisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.